APA (7th ed.) Citation

Niewczas, M. A., Mathew, A. V., Croall, S., Byun, J., Major, M., Sabisetti, V. S., . . . Krolewski, A. S. (2017). Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care, 40(3), 383. https://doi.org/10.2337/dc16-0173

Chicago Style (17th ed.) Citation

Niewczas, Monika A., et al. "Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease." Diabetes Care 40, no. 3 (2017): 383. https://doi.org/10.2337/dc16-0173.

MLA (9th ed.) Citation

Niewczas, Monika A., et al. "Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease." Diabetes Care, vol. 40, no. 3, 2017, p. 383, https://doi.org/10.2337/dc16-0173.